Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA, Nelson PJ, Spitzweg C. Schmohl KA, et al. Among authors: spitzweg c. Endocr Relat Cancer. 2019 Jun 1;26(6):R287-R304. doi: 10.1530/ERC-19-0058. Endocr Relat Cancer. 2019. PMID: 31063970 Review.
Gene therapy in thyroid cancer.
Spitzweg C. Spitzweg C. Horm Metab Res. 2009 Jun;41(6):500-9. doi: 10.1055/s-0029-1220744. Epub 2009 May 11. Horm Metab Res. 2009. PMID: 19434562 Review.
Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.
Knoop K, Kolokythas M, Klutz K, Willhauck MJ, Wunderlich N, Draganovici D, Zach C, Gildehaus FJ, Böning G, Göke B, Wagner E, Nelson PJ, Spitzweg C. Knoop K, et al. Among authors: spitzweg c. Mol Ther. 2011 Sep;19(9):1704-13. doi: 10.1038/mt.2011.93. Epub 2011 May 17. Mol Ther. 2011. PMID: 21587211 Free PMC article.
Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.
Knoop K, Schwenk N, Dolp P, Willhauck MJ, Zischek C, Zach C, Hacker M, Göke B, Wagner E, Nelson PJ, Spitzweg C. Knoop K, et al. Among authors: spitzweg c. Hum Gene Ther. 2013 Mar;24(3):306-16. doi: 10.1089/hum.2012.104. Hum Gene Ther. 2013. PMID: 23402366 Free PMC article.
Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C. Knoop K, et al. Among authors: spitzweg c. J Nucl Med. 2015 Apr;56(4):600-6. doi: 10.2967/jnumed.114.146662. Epub 2015 Mar 5. J Nucl Med. 2015. PMID: 25745085
Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Schmohl KA, Müller AM, Wechselberger A, Rühland S, Salb N, Schwenk N, Heuer H, Carlsen J, Göke B, Nelson PJ, Spitzweg C. Schmohl KA, et al. Among authors: spitzweg c. Endocr Relat Cancer. 2015 Dec;22(6):941-52. doi: 10.1530/ERC-15-0245. Epub 2015 Aug 25. Endocr Relat Cancer. 2015. PMID: 26307023
Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.
Urnauer S, Morys S, Krhac Levacic A, Müller AM, Schug C, Schmohl KA, Schwenk N, Zach C, Carlsen J, Bartenstein P, Wagner E, Spitzweg C. Urnauer S, et al. Among authors: spitzweg c. Mol Ther. 2016 Aug;24(8):1395-404. doi: 10.1038/mt.2016.95. Epub 2016 May 9. Mol Ther. 2016. PMID: 27157666 Free PMC article.
New drugs for medullary thyroid cancer: new promises?
Spitzweg C, Morris JC, Bible KC. Spitzweg C, et al. Endocr Relat Cancer. 2016 Jun;23(6):R287-97. doi: 10.1530/ERC-16-0104. Epub 2016 May 16. Endocr Relat Cancer. 2016. PMID: 27185870 Review.
Harnessing mesenchymal stem cell homing as an anticancer therapy.
Hagenhoff A, Bruns CJ, Zhao Y, von Lüttichau I, Niess H, Spitzweg C, Nelson PJ. Hagenhoff A, et al. Among authors: spitzweg c. Expert Opin Biol Ther. 2016 Sep;16(9):1079-92. doi: 10.1080/14712598.2016.1196179. Epub 2016 Jun 13. Expert Opin Biol Ther. 2016. PMID: 27270211 Review.
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Müller AM, Schmohl KA, Knoop K, Schug C, Urnauer S, Hagenhoff A, Clevert DA, Ingrisch M, Niess H, Carlsen J, Zach C, Wagner E, Bartenstein P, Nelson PJ, Spitzweg C. Müller AM, et al. Among authors: spitzweg c. Oncotarget. 2016 Aug 23;7(34):54795-54810. doi: 10.18632/oncotarget.10758. Oncotarget. 2016. PMID: 27458162 Free PMC article.
161 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback